Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 1
1999 3
2000 2
2001 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Cyclooxygenase inhibition and thrombogenicity.
Catella-Lawson F, Crofford LJ. Catella-Lawson F, et al. Am J Med. 2001 Feb 19;110 Suppl 3A:28S-32S. doi: 10.1016/s0002-9343(00)00683-5. Am J Med. 2001. PMID: 11173047 Review.
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
Lipsky PE, Abramson SB, Breedveld FC, Brook P, Burmester R, Buttgereit F, Cannon GW, Catella-Lawson F, Crofford LJ, Doherty M, Dougados M, DuBois RN, Froelich J, Garcia Rodriguez LA, Gibofsky A, Hernandez-Diaz S, Hochberg MC, Krause A, Liang MH, Machold K, Peloso PM, Raisz LG, Schayes B, Scheiman JM, Simon LS, Smolen J. Lipsky PE, et al. Among authors: catella lawson f. J Rheumatol. 2000 Jun;27(6):1338-40. J Rheumatol. 2000. PMID: 10852251 No abstract available.
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Catella-Lawson F, et al. N Engl J Med. 2001 Dec 20;345(25):1809-17. doi: 10.1056/NEJMoa003199. N Engl J Med. 2001. PMID: 11752357 Free article. Clinical Trial.
15 results